We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


GenMark Diagnostics Dismisses Patent Lawsuit Against Caliper Life Sciences

Want a FREE PDF version of this news story?

Complete the form below and we will email you a PDF version of "GenMark Diagnostics Dismisses Patent Lawsuit Against Caliper Life Sciences"

Listen with
Register for free to listen to this article
Thank you. Listen to this article using the player above.
Read time:

GenMark Diagnostics has announced that it has dismissed a lawsuit in the Northern District of California pending since November 2010 that requested declaratory relief that it does not infringe three U.S. patents on microfluidic technology allegedly owned by Caliper Life Sciences, Inc. The suit sought Declaratory Relief that GenMark does not infringe U.S.

Patent No. 6,366,924 entitled “Distributed Database for Analytical Instruments”; U.S. Patent No. 6,399,025 entitled “Analytical System and Method”; U.S. Patent No. 6,495,104 entitled “Indicator Components for Microfluidic Systems” and that these patents are invalid.